TY - JOUR
KW - opioid use disorder
KW - Low-threshold
KW - buprenorphine
KW - Mobile
KW - Hepatitis C
KW - integrated care
KW - Empirical Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Thirties (30-39 yrs)
KW - Middle Age (40-64 yrs)
KW - Hepatitis
KW - Urban Environments
KW - Clinics
KW - HIV Testing
KW - Vaccination
KW - Integrated Services
KW - article
KW - US
KW - 3340:Clinical Psychopharmacology
AU - Amanda Rosecrans
AU - Robert Harris
AU - Ronald E. Saxton
AU - Margaret Cotterell
AU - Meredith Zoltick
AU - Catherine Willman
AU - Ingrid Blackwell
AU - Joy Bell
AU - Darryl Hayes
AU - Brian Weir
AU - Susan Sherman
AU - Gregory M. Lucas
AU - Adena Greenbaum
AU - Kathleen R. Page
A1 - 
AD - Johns Hopkins University School of Medicine, Baltimore, MD, US arosecr1@jhmi.edu; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US ; Baltimore City Health Department, Baltimore, MD, US ; Rosecrans, Amanda,1200 E. Fayette St.,Baltimore,US,21202,Sexual Health and Wellness Clinic,arosecr1@jhmi.edu
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
DO - 10.1016/j.jsat.2021.108553
JF - Journal of substance abuse treatment
LA - English
M1 - Journal Article
PY - 2022
SN - 0740-5472, 0740-5472
SP - 7
T1 - Mobile low-threshold buprenorphine integrated with infectious disease services
T2 - Journal of substance abuse treatment
TI - Mobile low-threshold buprenorphine integrated with infectious disease services
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1016/j.jsat.2021.108553
UR - https://www.proquest.com/scholarly-journals/mobile-low-threshold-buprenorphine-integrated/docview/2551708858/se-2?accountid=28100
VL - 133
VO - 0740-5472, 0740-5472
Y1 - 2022
Y2 - 02
ER -